arrow
T

Tatsushi Kawada

Okayama University
H指数:17
被引数:1,456

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimizing low-dose rituximab protocol for ABO-mismatched kidney transplantation: long-term outcomes in a single-center retrospective cohort study

优化ABO血型不合肾移植的低剂量利妥昔单抗方案:单中心回顾性队列研究的长期结局

2026-05-010
OA
REAL-WORLD OUTCOMES OF IO-BASED FIRST-LINE THERAPY IN METASTATIC RENAL CELL CARCINOMA PATIENTS ON HEMODIALYSIS

IO-Based一线疗法在行血液透析的转移性肾细胞癌患者中的真实世界疗效

2026-05-010
PRE
NIVOLUMAB PLUS CABOZANTINIB VERSUS PEMBROLIZUMAB PLUS LENVATINIB FOR METASTATIC RENAL CELL CARCINOMA: A PROPENSITY SCORE-MATCHED ANALYSIS OF JAPANESE MULTICENTER DATABASE

纳武利尤单抗联合卡博替尼与帕博利珠单抗联合仑伐替尼治疗转移性肾细胞癌:基于日本多中心数据库的倾向性评分匹配分析

2026-05-010
PRE
DEVELOPMENT OF PROGNOSTIC MODEL INCORPORATING TUMOR BURDEN IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: RESULTS OF A MULTICENTER COHORT STUDY

纳入肿瘤负荷的转移性肾细胞癌患者预后模型的开发:一项多中心队列研究的结果

2026-05-010
PRE
Risk Factors for Perioperative Urinary Tract Infection After Living Donor Kidney Transplantation Characterized by High Prevalence of Desensitization Therapy: A Single-Center Analysis

活体供肾肾移植术后围手术期尿路感染的危险因素分析:一项以高致敏治疗发生率为主要特征的单一中心研究

2026-03-030
OAAI
A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium

一项针对真实世界中nivolumab联合cabozantinib与pembrolizumab联合lenvatinib在转移性肾细胞癌中的安全性结局比较研究:JK-FOOT联盟的结果

2026-02-250
OAAI
Safety and efficacy of Rezūm water vapour energy therapy in BPH patients receiving antithrombotic therapy: A Japanese single-centre experience

接受抗血栓治疗的前列腺增生患者中Rezūm水蒸气能量疗法的有效性和安全性:一项日本单中心经验

2026-02-010
OAAI
Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysis

延期全身性治疗对转移性肾细胞癌患者肿瘤学结局的影响:一项系统评价和定量分析

2026-01-010
PRE
Daytime Bladder Control Status in Toddlerhood Is Associated With Subsequent Bedwetting in Preschool Years: A Nationwide Cohort Study of Over 30 000 Japanese Children

幼儿期日间膀胱控制状况与学龄前夜间遗尿相关:一项针对超过30 000名日本儿童的国家队列研究

2025-11-011
OAAI
Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlook

尿路上皮癌免疫治疗反应的尿液生物标志物:现状与未来展望

2025-10-240
PRE
Rectal Swab–based Targeted Prophylactic Antibiotics Reduce Infectious Complications After Transrectal Prostate Biopsy: A Systematic Review and Meta-analysis of Randomized Controlled Trials

基于直肠拭子的靶向预防性抗生素可减少经直肠前列腺活检后的感染并发症:一项随机对照试验的系统评价和Meta分析

2025-09-110
PREAI
Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab

肾细胞癌患者接受伊匹木单抗联合纳武利尤单抗治疗时,早期进展性疾病及按转移部位的抗肿瘤效果的预测因子

2025-09-050
PRE
Outcome and Impact of Diagnostic Ureteroscopy in Clinically Suspected Upper Urinary Tract Carcinoma in Situ

临床可疑上尿路原位癌的诊断性输尿镜检查的结局与影响

2025-09-010
PRE
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact

解读RCC免疫治疗效果:日本多机构研究关于CANLPH评分影响的见解

2025-02-241
PRE
A Systematic Review and Meta-analysis of the Impact of Local Therapies on Local Event Suppression in Metastatic Hormone-sensitive Prostate Cancer
2024-12-011
OA
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis

辅助性免疫检查点抑制剂治疗肌层浸润性尿路上皮癌: 一项更新的系统评价、Meta分析和网络Meta分析

2024-11-130
PRE
Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis

小肾肿块患者主动监测与手术或消融治疗的肿瘤学结局:一项系统评价和定量分析

2024-10-010
OAAI
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasive Bladder Cancer
2024-06-012
PRE